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Summary Introduction: To provide optimal care for patients with chronic
obstructive pulmonary disease physicians need to understand if their patients
benefit from an intervention. The objective of this study was to assess agreement
between patients and physicians on health-related quality of life (HRQL) changes in
response to respiratory rehabilitation and to explore sources for disagreement.
Methods: Sixty-one patients rated their health states on a validated preference-
based instrument, the feeling thermometer (FT). In an analogous manner, the eight
treating physicians rated the patients’ health states on the FT. Patients and
physicians were blinded to each other’s ratings. We calculated intraclass correlation
coefficients (ICC) to assess agreement between patients and physicians and used
HRQL instruments and the 6-min walking test to assess the evaluative properties of
the FT.
Results: We found moderate agreement at baseline (ICC 0.40, P ¼ 0:018) and
follow-up (ICC 0.49, P ¼ 0:008) but large disagreement about change scores (ICC
0.02, P ¼ 0:46). Patients’ FTchange scores correlated well with change scores of the
Chronic Respiratory Questionnaire, SF-36 and the Borg scale for dyspnoea whereas
physicians’ FT change scores correlated significantly with the change score of the 6-
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min walking test (r ¼ 0:33). Physicians’ ratings showed an inconsistent pattern for
correlations with HRQL measures.
Conclusions: There is large disagreement between patients and physicians on
HRQL changes in response to respiratory rehabilitation. Investigators should assess
whether the introduction of HRQL instruments into clinical practice raises the
awareness of physicians towards HRQL and improves agreement with their patients.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
In patients suffering from chronic diseases, ascer-
tainment of treatment effects must include indivi-
dual patient’s symptoms and health-related quality
of life (HRQL).1,2 Physicians should have a vivid
understanding of patients’ symptoms and HRQL to
adequately evaluate the benefits from interven-
tions such as respiratory rehabilitation. Agreement
on HRQL changes between patients and physicians
indicates that physicians are able to understand the
patients’ perspective. This will help physicians to
inform future patients about the effects of respira-
tory rehabilitation on patient-important outcomes.
The aim of respiratory rehabilitation for patients
with chronic obstructive pulmonary disease (COPD)
is to improve HRQL and exercise capacity.1,2 There
is strong evidence that respiratory rehabilitation
leads to clinically relevant improvements of HRQL.3
Physicians should act on this evidence, but they
also need to evaluate the benefits and harms of
respiratory rehabilitation in their individual pa-
tients. However, there is little evidence about
physicians’ assessment of health status and HRQL
changes in individual patients with COPD and their
agreement with patients.1
Agreement between the patients’ and physi-
cians’ estimates of HRQL is an ongoing focus of
interest. Ratings scales and multidimensional HRQL
instruments have been used frequently to assess
patients’ and physicians’ estimations of general
health status,4,5 disease-specific HRQL6,7 or pain.8,9
In most of these studies, agreement between the
patients’ and physicians’ perspective was moderate
(intraclass correlation coefficients for most studies
between 0.5 and 0.6). Investigators10 suggested
that some disagreement may result from different
measurement properties of the HRQL instruments
in terms of validity and reliability when used by
patients and physicians.
Investigators use preference based instruments
to measure HRQL and to obtain utility estimates,11–
13 including the feeling thermometer (FT), a visual
analogue scale presented in the form of a thermo-
meter with 100 marked intervals.14 When complet-
ing this instrument, patients choose the score on
the thermometer that represents the value they
place on their health state. The FTworks well as an
evaluative instrument to assess HRQL. Two recent
randomised trials,15,16 the EuroQol17 and other
studies18–21 have shown the good responsiveness
and strong longitudinal validity of the FT.
We assessed how patients and their treating
physicians evaluated HRQL changes in response to
respiratory rehabilitation using the FT and we
explored the measurement properties of the FT
when used by patients and physicians as a potential
determinant influencing the level of agreement.
Methods
Study design
The data for this study were collected in a
randomised trial in which we assessed the measure-
ment properties of different administration for-
mats of the German Chronic Respiratory
Questionnaire (CRQ).22,23 In this present study, we
compared patients’ and physicians’ estimations of
changes in health status following therapy using the
FT.14 At baseline, we asked patients with COPD to
rate their general health status on the FT. After
completion of an intense respiratory rehabilitation
program we showed patients their baseline score
and asked them again to rate their general health
status on the FT considering their first score. In an
analogous manner, we asked physicians directly
involved in the care of the enrolled patients to
value the patients’ general health status on an
identical FT at baseline and follow-up. Physicians
and patients were blinded to each other’s ratings.
We did not intervene in the rehabilitation pro-
gramme apart from the baseline and follow-up
assessments. All local ethics committees approved
the study protocol and patients provided informed
consent prior to participation in the study.
Participants, physicians and intervention
We recruited consecutive COPD patients in four
rehabilitation clinics in Switzerland, Germany and
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Austria from August to November 2002 as described
previously.22 We selected respiratory rehabilitation
as the intervention because there is strong evi-
dence for its effectiveness to improve HRQL and
exercise capacity3 and it was therefore suitable for
our analysis. We included physicians who were
directly involved in the rehabilitative care of
patients enrolled in this study. The intense respira-
tory rehabilitation programmes followed the pub-
lished recommendations and consisted mainly of
physical exercise,2 but included also educational
and psychological sessions. The sessions lasted for
2–3 weeks and were continued for another 8 weeks
at lower intensity in ambulatory rehabilitation
sites.
Outcome assessment
We used the FT as an estimate for general health
status for both the patients and physicians. We
used defined anchors for the worst (dead¼ 0) and
best (perfect health¼ 100) health states to facil-
itate comparisons between individuals and
groups.24 We used an informed version of the FT,
i.e. patients and physicians could reflect in their
follow-up score the baseline estimate and the
improvement since then. The uninformed adminis-
tration of the FT may cause bias because physicians
might recall pretreatment scores more easily than
patients or vice versa. This bias would result in a
more informed estimation of the after treatment
scores in one group. In addition, previous studies
showed that informing patient of their pretreat-
ment scores improved measurement properties of
HRQL instruments when administered after inter-
vals of approximately 2 weeks.25
Additional outcome measures at baseline
and follow-up
We used informed versions of the self- and
interviewer-administered formats of the CRQ22,26
to assess COPD-specific HRQL. The 20 questions of
the CRQ provide summary scores for four domains
that are important to COPD patients (dyspnoea,
fatigue, emotional function and mastery). Patients
answer each of the 20 questions on a seven-point
scale expressing the degree of disability from 1
(maximum impairment) to 7 (no impairment). In
addition all patients completed 6-min walking
tests, the self-administered uninformed version of
the German SF-3627 and a modified Borg scale in
German28 to assess the intensity of perceived
dyspnoea at the end of the 6-min walking test.
The Borg scale consisted of a vertical line labeled
from 0 to 10 and with verbal descriptors. Zero
represented ‘‘no dyspnoea at all’’ and 10 ‘‘maximal
dyspnoea’’. Of the HRQL instrument, patients
completed the CRQ first, followed by the SF-36
and the FT.
Statistical analysis
We first determined the effectiveness of respira-
tory rehabilitation in our patients on a group level
using established outcomes measures such as the
CRQ and the 6-min walking test.3 We calculated
means and standard deviations for baseline, follow-
up and change scores of the CRQ and the 6-min
walking test and used paired t-tests to compare
baseline and follow-up scores. We determined the
proportion of patients whose change scores were
above the minimal clinically importance differ-
ence, which is 0.5 for the CRQ29,30 and around 50m
for the 6-min walking test.31
We then calculated means and standard devia-
tions for baseline, follow-up and change scores for
the FT of patients and physicians. We constructed
Bland Altman plots32 of the difference between the
estimates of each patient–physician pair against
the mean of their health status estimates (mean for
each patient–physician pair) to visualise if the
observed differences depended on the magnitude
of the FT estimates (e.g. more disagreement for
patients with worse health status). We developed
Bland–Altman plots for baseline, follow-up and
change scores to assess patient-physician agree-
ment. In addition, we calculated intraclass correla-
tion coefficients (two-way mixed effects model for
average measures) for baseline, follow-up and
change score agreement. The intraclass correlation
coefficient is more appropriate for assessing relia-
bility than the Pearson correlation coefficient
because it reflects random as well as systematic
differences in test scores.
We were interested in the evaluative properties
of the FT. We assessed responsiveness (the ability to
detect change in HRQL) using paired t-tests to
compare baseline and follow-up scores within
patients and physicians as well as unpaired t-tests
to compare change scores between patients and
physicians. We also determined the proportion of
patients and physicians whose change scores were
above the minimal clinically importance difference
of the FT of 8.33 We also assessed longitudinal
validity of the FT for patients and physicians, i.e.
whether the tendency for improvements or wor-
sening measured by the FTwas analogous compared
to other outcome measures such as the CRQ, the 6-
min walking test, the SF-36 (general health and
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vitality index) and the Borg scale. We calculated
Pearson correlation coefficients of the FT change
scores with change scores of these outcome
measures.
Finally, in a post hoc analysis we used linear
regression models with the difference between
patient and physician change scores as the depen-
dent variable to assess whether physician or patient
characteristics such as working experience, specia-
lisation, rehabilitation centres (two teaching and
one non-teaching hospital), patients’ age or disease
severity were significant independent predictors
for disagreement.
We set the statistical significance level at P-
valueso0.05. We performed all statistical analyses
with SPSS for Windows version 10.0 (SPSS Inc,
Chicago, IL).
Results
We initially enrolled 80 patients in this study, but
we had insufficient data for 9 patient–physician
pairs for the following reasons: three patients
withdrew for non-specified reasons, two did not
complete the rehabilitation (one patient suffered
from acute exacerbation and one discontinued the
rehabilitation program), three physicians did not
provide a FT score for the follow-up assessment
and, upon review, one patient did not meet the a
priori inclusion criteria. In addition, we excluded
all patients (n ¼ 10) recruited in Austria from the
analysis because the treating physician did not
remain blind to the patients’ FT scores. Thus, we
included data from 61 pairs with complete data
sets (61 patients and 8 physicians).
Table 1 presents the patient and physicians
characteristics at baseline. The physicians of the
four rehabilitation centres differed in their clinical
experience. Residents in one Swiss teaching hospi-
tal for rehabilitation medicine had a working or
training experience of 3 years or less. They
attended 1 year in the rehabilitation clinic as part
of their 5 years training program in internal
medicine or another discipline. In the other
hospitals, the physicians had completed their
training programs in internal medicine and two of
them had subspecialty training in respiratory or
rehabilitation medicine.
We observed not only significant differences
between baseline and follow-up scores in all CRQ
domains and the 6-min walking test (Table 2), but
61–77% of the patients had change scores above the
minimal clinically important difference on the CRQ
scores and 32% improved their functional exercise
capacity clinically meaningfully (450m). Thus the
patients’ health status improved over the course of
rehabilitation.
At baseline, patients estimated their health
states on the FT significantly higher than physicians
(P ¼ 0:015), while estimations at follow-up did not
differ significantly (P ¼ 0:23; see Table 3). The FT in
both patients and physicians indicated good re-
sponsiveness. But the physicians’ change scores
were on average 9.5 points larger (Po0:001)
compared to the patients’ estimates. Accordingly,
a larger proportion of patients had change scores
above 8 from the physicians’ perspective (93%)
compared to the patients’ perspective (66%).
The intraclass correlation coefficient was 0.40
(95% CI 0.01–0.63, P ¼ 0:018) for baseline agree-
ment, 0.46 (95% CI 0.11–0.68, P ¼ 0:008) for
follow-up agreement and 0.02 (95% CI 0.39–
0.34, P ¼ 0:46) for agreement of change scores.
The Bland Altman plots in Fig. 1 show the
differences between patients and physicians (y-
axis) and across the spectrum of disease severity (x-
axis). There was a systematic trend towards higher
baseline ratings by patients (data symbols above
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Table 1 Characteristics of participants.
Baseline characteristics
Physicians N ¼ 8
Age, mean years (SD) 38.1 (7.8)
Women, N 4
Status, N
Residents 4
Specialists 4
Internal medicine 4
Respiratory medicine 1
Rehabilitation medicine 2
Years since graduation
Residents, mean (SD) 2.75 (0.5)
Specialists, mean (SD) 15.74 (7.4)
Working in teaching hospital, No. 6
Patients N ¼ 61
Women, N (%) 18 (34.5)
Age, years, mean (SD) 69.0 (7.2)
FEV1, mean % predicted (SD) 43.8 (14.7)
FEV1/FVC, mean % predicted (SD) 48.5 (12.3)
6-min walking test, mean meters (SD) 358 (1 1 8)
Smoking, mean pack-years (SD) 45.8 (27.6)
Social status, N (%)
Living alone 20 (32.8%)
Working 9 (14.8)
Not working 8 (13.1)
Retired 44 (72.1)
Duration of rehabilitation,
mean days (SD)
16.8 (3.7)
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zero in upper plot) and higher change scores by
physicians (data symbols below zero in lower plot).
We show the longitudinal validity of the FT in
Table 4. The patient FT change scores showed
moderate to good correlations with all other HRQL
measures indicating that the FT is indeed a global
estimate for HRQL and symptoms (dyspnoea). The
patient FT change scores did not reflect changes of
exercise capacity as measured by the 6-min walking
test. In contrast, we observed for the physician FT
ratings the highest correlation with changes of
exercise capacity (r ¼ 0:36). Correlations with
HRQL measures were inconsistent and only signifi-
cant with the CRQ emotional function domain
(r ¼ 0:33).
Experience of physicians (B ¼ 4:8; P ¼ 0:63),
specialisation (B ¼ 7:7; P ¼ 0:74), rehabilitation
centres (B ¼ 1:6; P ¼ 0:75), disease severity
(B ¼ 0:2; P ¼ 0:16) and patients’ age (B ¼ 0:5;
P ¼ 0:09) were not significant predictors for dis-
agreement between patient and physician change
scores.
Discussion
In this analysis, we studied agreement between
patients and treating physicians on therapy related
HRQL gains. While agreement for health status at
baseline and follow-up was moderate, there was
large disagreement on change of health status. The
FT showed excellent responsiveness when used by
patients and physicians but only the patients’
ratings on the FT reflected HRQL changes
well. The patients’ FT changes scores correlated
consistently with established HRQL measures such
as the CRQ and the SF-36, while the physicians’
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Table 2 Effectiveness of respiratory rehabilitation.
Baseline Follow-up Change scores (range)
(CI, P-value)
Proportion of
patientsXMID
CRQ dyspnoea domain 3.78 (1.12) 4.68 (1.10) 0.90 (range 0.8 to 4.8) 61%
(0.63; 1.12; Po0:001)n
CRQ fatigue domain 3.99 (1.22) 5.01 (0.99) 1.02 (range –1.8 to 3.8) 77%
(0.83; 1.35; Po0:001)n
CRQ emotional function
domain
4.26 (1.15) 5.32 (0.90) 1.06 (range –1.3 to 3.9) 70%
(0.83; 1.30; Po0:001)n
CRQ mastery domain 4.36 (1.37) 5.39 (0.97) 1.03 (range –0.5–4.3) 70%
(0.75; 1.30; Po0:001)n
6-min walking test (m) 358.1 (115.2) 393.6 (120.5) 35.4 (range –132 to 140) 32%
(22.1–48.8; Po0:001)n
Values are mean (standard deviation).
nPaired t-tests (95% confidence intervals; P-value).
Table 3 Baseline, follow-up and change scores of the patients’ and physicians’ estimation of health status on the
FT.
Baseline Follow-up Change scores Proportion of
patientsXMID
Patient FT 50.3 (14.0)n 63.0 (15.7)n 12.7 (range –14 to 40) 66%
(10.0; 15.3; Po0:001)z
Physician FT 44.0 (14.4)n 66.2 (13.4)n 22.2 (range 0–55) 93%
(19.2; 25.1; Po0:001)z
Difference between
patients and physicians
6.3 3.2 9.5
(1.2; 11.4
P ¼ 0:015)w
(8.4; 2.1
P ¼ 0:23)w
(5.6; 13.4; Po0:001)w
nValues are mean (standard deviation).
wUnpaired t-tests (95% confidence intervals; P-value).
zPaired t-tests (95% confidence intervals; P-value).
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FT showed a different and inconsistent pattern of
correlations with the change scores of other
outcome measures.
The strength of our study includes the prospec-
tive study design that allowed blinding the patients
and physicians to each other’s ratings. In addition
we could not only explore patient and physician
factors that may explain some of the disagreement
but we also had outcome measures to assess the
evaluative properties of the FT.
The limitations of the study include the short
time between baseline and follow-up and one could
criticise that patients may not perceive the full
effect from respiratory rehabilitation despite gains
in function, until later.34 However, we did observe
treatment effects similar to those of other studies
about respiratory rehabilitation indicating that
patients achieved large improvement in HRQL.35,36
In addition, our study resembles clinical practice in
which the clinician has to assess patients after the
intense respiratory rehabilitation and before refer-
ring them to subsequent less intense programs. If
physicians caring for patients with COPD cannot
adequately evaluate the effect from respiratory
rehabilitation, the decision for referral is insecure.
Our study included 61 patient–physician pairs and a
larger number of pairs would have led to more
precise estimates of agreement. However, agree-
ment for baseline and follow-up scores, i.e. single
points of time, were similar compared to previous
studies that assessed agreement.10
There are several reasons for disagreement
between physician and patient ratings. We elimi-
nated bias by keeping patients and physicians blind
to each other’s HRQL measures. Therefore, ther-
apeutic actions were taken without discussing
these estimates and these conditions mimic current
clinical practice.37 Our data indicate that physi-
cians focused on objective outcomes such as the 6-
min walking test2 and included little patient
important outcomes in their rating of patients’
HRQL. In addition, physicians are generally more
familiar with outcome measures that reflect phy-
siological processes. The correlation of the emo-
tional function domain of the CRQ with the
physicians’ FT scores indicates that physicians
consider emotional function in their evaluation of
HRQL. For the patients, we confirmed the consis-
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Figure 1 The three Bland Altman plots show the
difference between patients’ and physicians’ baseline,
follow-up and change scores on the FT against the mean
of their baseline and follow-up scores. The middle line
represents full agreement between patients and physi-
cians (difference¼ zero) and the upper and lower line
two standard deviations of the FT baseline scores. There
is no clear trend that disease severity influenced
differences between patients and physicians (smaller
differences towards higher FT scores).
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tent correlation of the FT with HRQL measures as
observed in earlier studies15–17,38,39 and therefore
the good longitudinal validity of the FT. Thus, the
different measurement properties had an impact
on agreement as hypothesised earlier by Sneeuw
et al.10
The goals of respiratory rehabilitation are to
reduce symptoms and to enhance quality of life.
Established outcome measures are patient-impor-
tant and, therefore, the patient’s perspective must
be reflected in the physicians’ evaluation.40
However, our data suggest that this is not the case.
A recent study has shown that the use of HRQL
instruments in daily practice heightened the
physicians’ awareness of their patients’ HRQL.41
HRQL issues were explicitly discussed more
frequently and both patients and physicians
believed that the use of HRQL instruments facil-
itates communications in daily practice. Routine
discussion of HRQL in clinical practice may cali-
brate physicians’ perspective of HRQL gains in
response to therapy and may lead to realistic
evaluations and more adequate recommendations
to patients. Thus future research should focus on
interventions that increase the physicians’ aware-
ness and understanding of the perspective of COPD
patients’.
In conclusion, we found large disagreements
between patients and their physicians when esti-
mating HRQL gains in response to therapy. A likely
explanation is that patients indeed reflect HRQL in
their FT ratings whereas physicians include differ-
ent information when they are asked to evaluate
their patients’ HRQL gains. Investigators should
explore if the use of disease-specific HRQL instru-
ments and subsequent discussion of the results
between patients and physicians can raise the
physicians awareness of HRQL, reduce disagree-
ment between patients and physicians and whether
greater agreement leads to different behaviour for
recommendations of respiratory rehabilitation for
future patients.
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